miR-625 Reverses Multidrug Resistance in Gastric Cancer Cells by Directly Targeting ALDH1A1

Cancer Management and Research - New Zealand
doi 10.2147/cmar.s208708
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Informa UK Limited

Related search

MicroRNA‑134 Reverses Multidrug Resistance in Human Lung Adenocarcinoma Cells by Targeting FOXM1

Oncology Letters
Cancer ResearchOncology
2017English

MiR-139-5p Reverses CD44+/CD133+-associated Multidrug Resistance by Downregulating NOTCH1 in Colorectal Carcinoma Cells

Oncotarget
Oncology
2016English

Furosemide Reverses Multidrug Resistance Status in Bladder Cancer Cells in Vitro

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2006English

Targeting Multidrug Resistance in Cancer by Natural Chemosensitizers

Bulletin of the National Research Centre
2019English

ABT737 Reverses Cisplatin Resistance by Targeting Glucose Metabolism of Human Ovarian Cancer Cells

International Journal of Oncology
Cancer ResearchOncology
2018English

MiR–20a-5p Promotes Radio-Resistance by Targeting Rab27B in Nasopharyngeal Cancer Cells

Cancer Cell International
Cancer ResearchOncologyGenetics
2017English

miR‑625‑5p Suppresses Inflammatory Responses by Targeting AKT2 in Human Bronchial Epithelial Cells

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

Knockdown of Long Non‑coding RNA PVT1 Reverses Multidrug Resistance in Colorectal Cancer Cells

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

MiR-744-5p Inducing Cell Death by Directly Targeting HNRNPC and NFIX in Ovarian Cancer Cells

Scientific Reports
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy